Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001493152-26-001846
Filing Date
2026-01-12
Accepted
2026-01-12 16:05:07
Documents
1
Period of Report
2026-01-08

Document Format Files

Seq Description Document Type Size
1 3 ownership.html 3  
1 3 ownership.xml 3 2165
  Complete submission text file 0001493152-26-001846.txt   3668
Mailing Address 6720 NW 74TH COURT PARKLAND FL 33067
Business Address
NATAN DAVID (Reporting) CIK: 0001253108 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-40652 | Film No.: 26526727

Mailing Address 3 COLUMBUS CIRCLE 15TH FLOOR NEW YORK NY 10019
Business Address 3 COLUMBUS CIRCLE 15TH FLOOR NEW YORK NY 10019 (646) 427-2727
Indaptus Therapeutics, Inc. (Issuer) CIK: 0001857044 (see all company filings)

EIN.: 863158720 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)